NASDAQ: VIVS
Vivosim Labs Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their VIVS stock forecasts and price targets.

Forecast return on equity

Is VIVS forecast to generate an efficient return?

Company
-245.33%
Industry
50.63%
Market
-24.76%
VIVS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VIVS forecast to generate an efficient return on assets?

Company
-195.35%
Industry
14.75%
VIVS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VIVS revenue growth forecast

How is VIVS forecast to perform vs Biotechnology companies and vs the US market?

Company
27.27%
Industry
260.84%
Market
13.12%
VIVS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VIVS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VIVS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VIVS$2.56N/AN/A
PMCB$0.97N/AN/A
TCRT$3.07N/AN/A
MBIO$1.50N/AN/A
XBIO$4.21N/AN/A

Vivosim Labs Stock Forecast FAQ

What is VIVS's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: VIVS) forecast ROE is -245.33%, which is considered weak.

If you're new to stock investing, here's how to buy Vivosim Labs stock.

What is VIVS's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: VIVS) forecast ROA is -195.35%, which is lower than the forecast US Biotechnology industry average of 14.75%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.